Rockville, Md. – July 5 — The American Dental Association (ADA) along with four other dental specialty organizations told the Food and Drug Administration that dental procedures can provide relevant efficacy and safety data as the FDA develops guidance on clinical development programs for sedation products.
To read the full press release from the ADA, click here.
